Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 314.2 AUD 1.36% Market Closed
Market Cap: 32.8B AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PME stock under the Base Case scenario is 26.15 AUD. Compared to the current market price of 314.2 AUD, Pro Medicus Ltd is Overvalued by 92%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PME Relative Value
Base Case
26.15 AUD
Overvaluation 92%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

172.3
P/S
P/S
Price to Sales
172.3
vs History
0
vs Industry
2
Median 3Y
71.9
Median 5Y
71.9
Industry
2.3
Forward
147
More Details
334.6
P/E
P/E
Price to Earnings
334.6
vs History
0
vs Industry
1
Median 3Y
150.8
Median 5Y
150.8
Industry
22
Forward
285
More Details
323.3
P/OCF
P/OCF
Price to OCF
323.3
vs History
1
vs Industry
1
Median 3Y
147.1
Median 5Y
138.9
Industry
14.2
More Details
349.3
P/FCFE
P/FCFE
Price to FCFE
349.3
vs History
1
vs Industry
2
Median 3Y
163.4
Median 5Y
158.7
Industry
19.9
More Details
147.7
P/B
P/B
Price to Book Value
147.7
vs History
0
vs Industry
0
Median 3Y
66
Median 5Y
62.9
Industry
2.2
More Details
171.3
EV/S
EV/S
Enterprise Value to Sales
171.3
vs History
0
vs Industry
2
Median 3Y
71
Median 5Y
71
Industry
2.4
Forward
146.2
More Details
171.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
171.6
vs History
0
vs Industry
2
Median 3Y
71.2
Median 5Y
71.2
Industry
4.9
More Details
234.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
234.1
vs History
0
vs Industry
1
Median 3Y
103.6
Median 5Y
106.4
Industry
11.6
Forward
189.9
More Details
234.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
234.1
vs History
0
vs Industry
2
Median 3Y
103.6
Median 5Y
106.4
Industry
15.9
Forward
207.2
More Details
321.5
EV/OCF
EV/OCF
Enterprise Value to OCF
321.5
vs History
0
vs Industry
1
Median 3Y
145.2
Median 5Y
137.4
Industry
14.2
More Details
345.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
345.8
vs History
1
vs Industry
2
Median 3Y
160
Median 5Y
155.4
Industry
17.8
More Details
293.9
EV/IC
EV/IC
Enterprise Value to IC
293.9
vs History
0
vs Industry
0
Median 3Y
119.7
Median 5Y
89.4
Industry
1.8
More Details

Multiples Across Competitors

PME Competitors Multiples
Pro Medicus Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Pro Medicus Ltd
ASX:PME
32.9B AUD 172.3 334.6 234.1 234.1
US
Veeva Systems Inc
NYSE:VEEV
45.7B USD 16 58.5 48.9 51.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
US
Doximity Inc
NYSE:DOCS
11.5B USD 20.2 51.5 43.9 46
JP
M3 Inc
TSE:2413
1.3T JPY 4.6 32.4 18.4 22.1
SE
Sectra AB
STO:SECT B
67.7B SEK 32.8 120.2 -148.3 -148.3
US
Waystar Holding Corp
NASDAQ:WAY
6.7B USD 6.8 256.2 23.2 49.8
US
Inspire Medical Systems Inc
NYSE:INSP
3.7B USD 4.5 56.2 57.5 67.7
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
261.9B INR 0 0 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
21.6B CNY 8.2 282.7 97.1 97.1
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -331.9 271.2 4 341.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Pro Medicus Ltd
ASX:PME
Average EV/EBITDA: 90.7
234.1
38%
6.2
US
Veeva Systems Inc
NYSE:VEEV
48.9
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Doximity Inc
NYSE:DOCS
43.9
21%
2.1
JP
M3 Inc
TSE:2413
18.4
13%
1.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -148.3 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
23.2
18%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
57.5
90%
0.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
97.1
48%
2
US
V
Vocera Communications Inc
F:V00
271.2
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Pro Medicus Ltd
ASX:PME
Average EV/EBIT: 550.3
234.1
36%
6.5
US
Veeva Systems Inc
NYSE:VEEV
51.5
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
US
Doximity Inc
NYSE:DOCS
46
22%
2.1
JP
M3 Inc
TSE:2413
22.1
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -148.3 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
49.8
40%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
67.7
64%
1.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
97.1
47%
2.1
US
V
Vocera Communications Inc
F:V00
4 341.8
N/A N/A

See Also

Summary
PME intrinsic value, competitors valuation, and company profile.
DCF Valuation
PME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PME stock valuation using valuation multiples.
Wall Street Estimates
PME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 266,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.